Enveric Biosciences

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell ENVB and other ETFs, options, and stocks.

About ENVB

Enveric Biosciences, Inc. is a biotechnology company which engages in the development of neuroplastogenic small-molecule therapeutics for the treatment of depression, anxiety, addiction, and other psychiatric disorders. The company was founded on February 28, 1994 and is headquartered in Cambridge, MA. 

CEO
Joseph Tucker
CEOJoseph Tucker
Employees
6
Employees6
Headquarters
Cambridge, Massachusetts
HeadquartersCambridge, Massachusetts
Founded
1994
Founded1994
Employees
6
Employees6

ENVB Key Statistics

Market cap
6.46M
Market cap6.46M
Price-Earnings ratio
-0.06
Price-Earnings ratio-0.06
Dividend yield
Dividend yield
Average volume
147.41K
Average volume147.41K
High today
$1.93
High today$1.93
Low today
$1.45
Low today$1.45
Open price
$1.57
Open price$1.57
Volume
413.38K
Volume413.38K
52 Week high
$17.64
52 Week high$17.64
52 Week low
$1.25
52 Week low$1.25

Stock Snapshot

As of today, Enveric Biosciences(ENVB) shares are valued at $1.67. The company's market cap stands at 6.46M, with a P/E ratio of -0.06.

On 2026-08-05, Enveric Biosciences(ENVB) stock moved within a range of $1.45 to $1.93. With shares now at $1.67, the stock is trading +15.2% above its intraday low and -13.5% below the session's peak.

Trading activity shows a volume of 413.38K, compared to an average daily volume of 147.41K.

Over the past 52 weeks, Enveric Biosciences(ENVB) stock has traded between a high of $17.64 and a low of $1.25.

Over the past 52 weeks, Enveric Biosciences(ENVB) stock has traded between a high of $17.64 and a low of $1.25.

ENVB News

TipRanks 12h
Enveric Biosciences reports new preclinical data on EB-003

Enveric Biosciences (ENVB) announced new preclinical data that further supports the growing body of evidence reinforcing the non-hallucinogenic profile of its l...

Benzinga 13h
Enveric Biosciences Says New Preclinical Data Confirms Non-Hallucinogenic Profile For Lead Psychiatric Ca - Benzinga

...

Enveric Biosciences Says New Preclinical Data Confirms Non-Hallucinogenic Profile For Lead Psychiatric Ca - Benzinga

People also own

Based on the portfolios of people who own ENVB. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.